Impact of Adjuvant Radiotherapy in Squamous Cell Carcinoma of the Oral Cavity with Perineural Invasion.

adjuvant radiotherapy locoregional control oral cavity cancer perineural invasion survival

Journal

The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378

Informations de publication

Date de publication:
17 Nov 2023
Historique:
revised: 07 10 2023
received: 19 07 2023
accepted: 13 10 2023
medline: 17 11 2023
pubmed: 17 11 2023
entrez: 17 11 2023
Statut: aheadofprint

Résumé

Current guidelines indicate postoperative radiotherapy (PORT) in oral squamous cell carcinoma (OSCC) with perineural invasion (PNI), however, its real benefit has never been proven. The aim of our study is to investigate the benefit of PORT in OSCC patients with PNI in terms of survival and disease control. The Pubmed/MEDLINE, Cochrane Library, and Scopus databases. Patients with PNI + OSCC treated with primary surgery were extracted from the included studies. The pooled logHR was calculated by comparing patients who underwent PORT to those who underwent only observation for overall survival (OS), disease-specific survival (DSS), disease-free survival (DFS), and locoregional control (LRC). About 690 patients with primary OSCC and PNI were included from nine studies. 374 (54.2%) patients underwent PORT, while 316 (45.8%) underwent observation. Analyses showed non-significant difference between the two groups for OS (HR: 1.01; 95% CI: 0.38-2.69), DSS (HR: 2.03; 95% CI: 0.54-7.56), and LRC (HR: 0.89; 95% CI: 0.53-1.50). They showed a significant difference in terms of DFS (HR: 0.86; 95% CI: 0.77-0.97). The real benefit of PORT in OSCC patients with PNI is still unclear, although it may have a positive impact on DFS. Clinicians should consider individual patient's characteristics, tumor factors, and treatment goals when deciding whether to recommend PORT. Further studies are needed to clarify which entity of PNI really benefits from PORT. N/A Laryngoscope, 2023.

Identifiants

pubmed: 37975480
doi: 10.1002/lary.31148
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023 The American Laryngological, Rhinological and Otological Society, Inc.

Références

National Comprehensive Cancer Network. Head and Neck Cancers (version 1.2022). https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf.
Montero PH, Patel SG. Cancer of the oral cavity. Surg Oncol Clin N Am. 2015;24(3):491-508. https://doi.org/10.1016/j.soc.2015.03.006.
Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005;27(10):843-850. https://doi.org/10.1002/hed.20279.
Schmitd LB, Beesley LJ, Russo N, et al. Redefining perineural invasion: integration of biology with clinical outcome. Neoplasia U S. 2018;20(7):657-667. https://doi.org/10.1016/j.neo.2018.04.005.
Binmadi NO, Basile JR. Perineural invasion in oral squamous cell carcinoma: a discussion of significance and review of the literature. Oral Oncol. 2011;47(11):1005-1010. https://doi.org/10.1016/j.oraloncology.2011.08.002.
Rahima B, Shingaki S, Nagata M, Saito C. Prognostic significance of perineural invasion in oral and oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97(4):423-431. https://doi.org/10.1016/j.tripleo.2003.10.014.
Woolgar JA. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 2006;42(3):229-239. https://doi.org/10.1016/j.oraloncology.2005.05.008.
McMahon JD, Robertson GAJ, Liew C, et al. Oral and oropharyngeal cancer in the west of Scotland-long-term outcome data of a prospective audit 1999-2001. Br J Oral Maxillofac Surg. 2011;49(2):92-98. https://doi.org/10.1016/j.bjoms.2009.12.013.
Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777-784. https://doi.org/10.7326/M14-2385.
Methley AM, Campbell S, Chew-Graham C, McNally R, Cheraghi-Sohi S. PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Serv Res. 2014;14(1):579. https://doi.org/10.1186/s12913-014-0579-0.
National Institute for Health and Care Excellence. Methods for the Development of NICE Public Health Guidance. London: National Institute for Health and Care Excellence (NICE). 2012.
McGrath S, Zhao X, Qin ZZ, Steele R, Benedetti A. One-sample aggregate data meta-analysis of medians. Stat Med. 2019;38(6):969-984. https://doi.org/10.1002/sim.8013.
Jackson D, White IR, Riley RD. Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med. 2012;31(29):3805-3820. https://doi.org/10.1002/sim.5453.
Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8(1):16. https://doi.org/10.1186/1745-6215-8-16.
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14(1):135. https://doi.org/10.1186/1471-2288-14-135.
Veroniki AA, Dan J, Viechtbauer W, et al. Methods to estimate the between-studyvariance and its uncertainty inmeta-analysis. Res Synth Methods. 2016;7(1):55-79. https://doi.org/10.1002/jrsm.1164.
Viechtbauer W, Cheung MWL. Outlier and influence diagnostics for meta-analysis. Res Synth Methods. 2010;1(2):112-125. https://doi.org/10.1002/jrsm.11.
Baujat B, Mahé C, Pignon JP, Hill C. A graphical method for exploring heterogeneity in META-analyses: application to a META-analysis of 65 trials. Stat Med. 2002;21(18):2641-2652. https://doi.org/10.1002/sim.1221.
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634. https://doi.org/10.1136/bmj.315.7109.629.
Chien JC, Hu YC, Chang KC, et al. Contralateral lymph node recurrence rate and its prognostic factors in stage IVA-B well-lateralized oral cavity cancer. Auris Nasus Larynx. 2021;48(5):991-998. https://doi.org/10.1016/j.anl.2021.01.016.
Chinn SB, Spector ME, Bellile EL, et al. Impact of perineural invasion in the pathologically N0 neck in oral cavity squamous cell carcinoma. Otolaryngol Head Neck Surg U S. 2013;149(6):893-899. https://doi.org/10.1177/0194599813506867.
Hasmat S, Ebrahimi A, Gao K, et al. Multifocal perineural invasion is a better prognosticator than depth of invasion in oral squamous cell carcinoma. Head Neck. 2019;41(11):3992-3999. https://doi.org/10.1002/hed.25940.
Larson AR, Kemmer J, Formeister E, et al. Beyond depth of invasion: adverse pathologic tumor features in early oral tongue squamous cell carcinoma. Laryngoscope. 2020;130(7):1715-1720. https://doi.org/10.1002/lary.28241.
Liao CT, Chang JTC, Wang HM, et al. Does adjuvant radiation therapy improve outcomes in pT1-3N0 oral cavity cancer with tumor-free margins and perineural invasion? Int J Radiat Oncol Biol Phys. 2008;71(2):371-376. https://doi.org/10.1016/j.ijrobp.2007.10.015.
Nair D, Mair M, Singhvi H, et al. Perineural invasion: independent prognostic factor in oral cancer that warrants adjuvant treatment. Head Neck. 2018;40(8):1780-1787. https://doi.org/10.1002/hed.25170.
Rajappa SK, Ram D, Shukla H, et al. Oncological benefits of postoperative radiotherapy in node-negative early stage cancer of the oral cavity with isolated perineural invasion. Br J Oral Maxillofac Surg. 2019;57(5):454-459. https://doi.org/10.1016/j.bjoms.2019.04.002.
Holcomb J, Farrokhian N, Tolan C, et al. Adjuvant radiotherapy mitigates impact of perineural invasion on oncologic outcomes in early-stage oral cavity squamous cell carcinoma. A multi-institutional analysis of 557 patients. Oral Oncol. 2023;142:106420.
Singareddy R, Bajwa H, Reddy M, et al. Does adjuvant radiation therapy improve outcomes in pT1-2N0 oral tongue squamous cell carcinoma patients with isolated perineural invasion? J Dent Oral Disord. 2016;2:1019.
Zanoni DK, Montero PH, Migliacci JC, et al. Survival outcomes after treatment of cancer of the oral cavity (1985-2015). Oral Oncol. 2019;90:115-121. https://doi.org/10.1016/j.oraloncology.2019.02.001.
Quintana DMVO, Dedivitis RA, Kowalski LP. Prognostic impact of perineural invasion in oral cancer: a systematic review. Acta Otorhinolaryngol Ital. 2022;42(1):17-25. https://doi.org/10.14639/0392-100X-N1653.
Vonk J, Smit KA, Roodenburg JLN, et al. Effect of adjuvant radiotherapy on the local recurrence of oral squamous cell carcinoma with perineural invasion: a systematic review. Clin Otolaryngol. 2019;44(2):131-137. https://doi.org/10.1111/coa.13239.

Auteurs

Bianca Maria Festa (BM)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.

Andrea Costantino (A)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.

Gian Marco Pace (GM)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.

Gerardo Petruzzi (G)

Department of Otolaryngology-Head and Neck Surgery, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Flaminia Campo (F)

Department of Sense Organs, Sapienza University of Rome, Rome, Italy.

Raul Pellini (R)

Department of Otolaryngology-Head and Neck Surgery, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Giuseppe Spriano (G)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.

Armando De Virgilio (A)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.

Classifications MeSH